Skip to main content
SpringerLink
Log in

18F-FDG PET/CT: Normal Variants, Artifacts, and Pitfalls in Lung Cancer

  • Chapter
  • First Online:
PET/CT in Lung Cancer

Part of the book series: Clinicians’ Guides to Radionuclide Hybrid Imaging ((PET/CT))

  • 1142 Accesses

Abstract

18F-2-Fluoro-2-deoxyglucose (FDG) is the workhorse of oncological PET/CT departments. Its role in staging, restaging, and response assessment of various cancers is already established. But FDG is a marker of glycolysis and, thus, is neither specific for malignancy nor for a particular tumor. Its accumulation can be seen in benign process which may be difficult to differentiate from a neoplastic etiology. It is imperative that nuclear physicians and radiologists know about these FDG-avid benign pathologies and few FDG-negative malignant etiologies, which may confound correct interpretation in PET/CT reporting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Beyer T, Antoch G, Blodgett T, et al. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging. 2003;30:588–96.

    Article  PubMed  Google Scholar 

  2. Nehmeh SA, Erdi YE, Kalaigian H, et al. Correction for oral contrast artifacts in CT attenuation corrected PET images obtained by combined PET/CT. J Nucl Med. 2003;44:1940–4.

    PubMed  Google Scholar 

  3. Liu Y, Ghesani NV, Zuckier LS. Physiology and pathophysiology of incidental findings detected on FDG-PET scintigraphy. Semin Nucl Med. 2010;40(4):294–315.

    Article  PubMed  Google Scholar 

  4. Farsad M, Ambrosini V, Nanni C, et al. Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. Nucl Med Commun. 2005;26(9):827–30.

    Article  PubMed  Google Scholar 

  5. Ozdemir E, Poyraz NY, Keskin M, Kandemir Z, Turkolmez S. Hot-clot artifacts in the lung parenchyma on F-18 fluorodeoxyglucose positron emission tomography/CT due to faulty injection techniques: two case reports. Korean J Radiol. 2014;15(4):530–3.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 1992;33:1972–80.

    CAS  PubMed  Google Scholar 

  7. Paik JY, Lee KH, Choe YS, et al. Augmented 18F-FDG uptake in activated monocytes occurs during the priming process and involves tyrosine kinases and protein kinase C. J Nucl Med. 2004;45:124–8.

    CAS  PubMed  Google Scholar 

  8. Bakheet SM, Powe J, Ezzat A, et al. F-18-FDG uptake in tuberculosis. Clin Nucl Med. 1998;23:739–42.

    Article  CAS  PubMed  Google Scholar 

  9. Skoura E, Zumla A, Bomanji J. Imaging in tuberculosis. Int J Infect Dis. 2015;32:87–93.

    Article  PubMed  Google Scholar 

  10. Lewis PJ, Salama A. Uptake of fluorine-18-deoxyglucose uptake in sarcoidosis. J Nucl Med. 1994;35:1647–9.

    CAS  PubMed  Google Scholar 

  11. Yasuda S, Shothsu A, Ide M, et al. High fluorine-18-deoxyglucose uptake in sarcoidosis. Clin Nucl Med. 1996;21:983–4.

    Article  CAS  PubMed  Google Scholar 

  12. El-Haddad G, Zhuang H, Gupta N, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34(4):313–29.

    Article  PubMed  Google Scholar 

  13. Sobic-Saranovic D, Artiko V, Obradovic V. FDG PET imaging in sarcoidosis. Semin Nucl Med. 2013;43(6):404–11.

    Article  PubMed  Google Scholar 

  14. Quan XQ, Yin TJ, Zhang CT, Liu J, Qiao LF, Ke CS. (18)F-FDG PET/CT in patients with nodular pulmonary amyloidosis: case report and literature review. Case Rep Oncol. 2014;7(3):789–98.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wachsmann JW, Gerbaudo VH. Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging. PET Clin. 2014;9(2):147–68.

    Article  PubMed  Google Scholar 

  16. Kwek BH, Aquino SL, Fischman AJ. Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest. 2004;125:2356–60.

    Article  PubMed  Google Scholar 

  17. Ahmadzadehfar H, Palmedo H, Strunk H, Biersack HJ, Habibi E, Ezziddin S. False positive 18F-FDG-PET/CT in a patient after talc pleurodesis. Lung Cancer. 2007;58(3):418–21.

    Article  PubMed  Google Scholar 

  18. Ulaner GA, Lyall A. Identifying and distinguishing treatment effects and complications from malignancy at FDG PET/CT. Radiographics. 2013;33(6):1817–34.

    Article  PubMed  Google Scholar 

  19. de Prost N, Tucci MR, Melo MF. Assessment of lung inflammation with 18F-FDG PET during acute lung injury. AJR Am J Roentgenol. 2010;195(2):292–300.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kamel EM, Goerres GW, Burger C, et al. Recurrent laryngeal nerve palsy in patients with lung cancer: detection with PET/CT image fusion—report of six cases. Radiology. 2002;224:153–6.

    Google Scholar 

  21. Lee M, Ramaswamy MR, Lilien DL, et al. Unilateral vocal cord paralysis causes contralateral false-positive positron emission tomography scans of the larynx. Ann Otol Rhinol Laryngol. 2005;114:202–6.

    Article  PubMed  Google Scholar 

  22. Peter Klussmen J, Wittekindt C, Florian Preuss S, et al. High risk for bilateral warthin tumor in heavy smokers - review of 185 cases. Acta Otolaryngol. 2006;126:1213–7.

    Article  Google Scholar 

  23. Lee SK, Rho BH, Won KS. Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at gray-scale and power Doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core biopsy. Eur Radiol. 2009;19:2268–74.

    Article  PubMed  Google Scholar 

  24. Inoue K, Okada K, Harigae H, et al. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Clin Nucl Med. 2006;31:721–3.

    Article  PubMed  Google Scholar 

  25. Higashi K, Ueda Y, Sakurai A, et al. Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer. Eur J Nucl Med. 2000;27:1778–85.

    Article  CAS  Google Scholar 

  26. Stefani A, Franceschetto A, Nesci J, Aramini B, Proli C, Kaleci S, et al. Integrated FDG-PET/CT imaging is useful in the approach to carcinoid tumors of the lung. J Cardiothorac Surg. 2013;8:223.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Nomori H, Watanabe K, Ohtsuka T, et al. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer. 2004;45:19–27.

    Article  PubMed  Google Scholar 

  28. Cook GJ, Wegner EA, Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med. 2004;34(2):122–33.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital, Mumbai, India

    Archi Agrawal MBBS, DMRE, DRM, DNB & Venkatesh Rangarajan MBBS, DRM, DNB

Authors
  1. Archi Agrawal MBBS, DMRE, DRM, DNB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Venkatesh Rangarajan MBBS, DRM, DNB
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Archi Agrawal MBBS, DMRE, DRM, DNB .

Editor information

Editors and Affiliations

  1. Department of Nuclear Medicine & Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India

    Archi Agrawal

  2. Department of Nuclear Medicine & Molecular Imaging, Tata Memorial Hospital, Mumbai, Maharashtra, India

    Venkatesh Rangarajan

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Agrawal, A., Rangarajan, V. (2018). 18F-FDG PET/CT: Normal Variants, Artifacts, and Pitfalls in Lung Cancer. In: Agrawal, A., Rangarajan, V. (eds) PET/CT in Lung Cancer. Clinicians’ Guides to Radionuclide Hybrid Imaging(). Springer, Cham. https://doi.org/10.1007/978-3-319-72661-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-72661-8_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-72660-1

  • Online ISBN: 978-3-319-72661-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation